EDESA BIOTECH, INC. Deferred Tax Assets, Other Loss Carryforwards
EDESA BIOTECH, INC. (EDSA) had Deferred Tax Assets, Other Loss Carryforwards of $731.00 thousand as of 2023-09-30, per its 10-K filed 2023-12-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOtherLossCarryforwards · last filed 2023-12-15
- 2023-09-30: Deferred Tax Assets, Other Loss Carryforwards $731.00K.
- 2022-09-30: Deferred Tax Assets, Other Loss Carryforwards $1.63M.
- 2021-09-30: Deferred Tax Assets, Other Loss Carryforwards $1.63M.
- 2020-09-30: Deferred Tax Assets, Other Loss Carryforwards $1.61M.
| Period end | Deferred Tax Assets, Other Loss Carryforwards | Deferred Tax Assets, Other Loss Carryforwards as first filed |
|---|---|---|
| 2023-09-30 | $731.00K 10-K · filed 2023-12-15 | |
| 2022-09-30 | $1.63M 10-K · filed 2023-12-15 | |
| 2021-09-30 | $1.63M 10-K · filed 2022-12-16 | |
| 2020-09-30 | $1.61M 10-K · filed 2021-12-28 | |
| 2019-09-30 | $1.59M 10-K · filed 2020-12-07 | $587.00K 10-KT · filed 2019-12-12 |
| 2018-12-31 | $0.00 10-KT · filed 2019-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |